Cyclophosphamide and Cytomegalovirus urinary tract infection - a phase IV clinical study of FDA data
Summary:
Cytomegalovirus urinary tract infection is reported as a side effect among people who take Cyclophosphamide (cyclophosphamide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Busulfan, and have Bone marrow conditioning regimen.
The phase IV clinical study analyzes which people have Cytomegalovirus urinary tract infection when taking Cyclophosphamide. It is created by eHealthMe based on reports of 185,094 people who have side effects when taking Cyclophosphamide from the FDA, and is updated regularly.
What is Cyclophosphamide?
Cyclophosphamide has active ingredients of cyclophosphamide. It is often used in multiple myeloma. eHealthMe is studying from 185,240 Cyclophosphamide users. Check the latest studies of Cyclophosphamide.
What is Cytomegalovirus urinary tract infection?
Cytomegalovirus urinary tract infection (infection with cytomegalo virus) is found to be associated with 6 drugs and 9 conditions by eHealthMe. Check the latest studies of Cytomegalovirus urinary tract infection.
185,094 people reported to have side effects when taking Cyclophosphamide.
Among them, 24 people (0.01%) have Cytomegalovirus urinary tract infection.
Among these 24 people:
How long have people been on Cyclophosphamide when they have Cytomegalovirus urinary tract infection? *
- < 1 month: 0.0 %
- 1 - 6 months: 100 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Cytomegalovirus urinary tract infection when taking Cyclophosphamide? *
- female: 88.24 %
- male: 11.76 %
What is the age of people who have Cytomegalovirus urinary tract infection when taking Cyclophosphamide? *
- 0-1: 0.0 %
- 2-9: 15.79 %
- 10-19: 0.0 %
- 20-29: 5.26 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 78.95 %
What are other drugs people take besides Cyclophosphamide? *
- Busulfan: 22 people, 91.67%
- Thiotepa: 17 people, 70.83%
- Mycophenolate Mofetil: 17 people, 70.83%
- Ursodiol: 16 people, 66.67%
- Tacrolimus: 16 people, 66.67%
- Cyclosporine: 6 people, 25.00%
- Methylprednisolone: 5 people, 20.83%
- Fludarabine Phosphate: 2 people, 8.33%
- Cytarabine: 2 people, 8.33%
- Rituxan: 1 person, 4.17%
What are other side effects people have besides Cytomegalovirus urinary tract infection? *
- Pleural Effusion (water on the lungs): 20 people, 83.33%
- Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 16 people, 66.67%
- Ascites (accumulation of fluid in the abdominal cavity): 16 people, 66.67%
- Pericardial Effusion (fluid around the heart): 16 people, 66.67%
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 5 people, 20.83%
- Bleeding Disorders: 4 people, 16.67%
- Death: 4 people, 16.67%
- Fever: 4 people, 16.67%
- Pneumonia Fungal: 4 people, 16.67%
- Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 4 people, 16.67%
What are the existing conditions these people have? *
- Bone Marrow Conditioning Regimen: 22 people, 91.67%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 16 people, 66.67%
- Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 6 people, 25.00%
- Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 1 person, 4.17%
- Acute Graft Versus Host Disease In Skin (acute complication on skin following an allogeneic tissue/blood transplant): 1 person, 4.17%
* Approximation only. Some reports may have incomplete information.
Do you take Cyclophosphamide and have Cytomegalovirus urinary tract infection?
- Check whether Cytomegalovirus urinary tract infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Cyclophosphamide:
- Cyclophosphamide (185,240 reports)
Cytomegalovirus urinary tract infection treatments and more:
- Cytomegalovirus urinary tract infection (42 reports)
How severe was Cytomegalovirus urinary tract infection and when was it recovered:
Expand to all the drugs that have ingredients of cyclophosphamide:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cyclophosphamide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Cytomegalovirus urinary tract infection:
- Cytomegalovirus urinary tract infection (6 drugs)
Browse all the conditions that are associated with Cytomegalovirus urinary tract infection:
- Cytomegalovirus urinary tract infection (9 conditions)
Related publications that referenced our studies
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
- Hu P, Lu L, Hu B, Deng F, Fei WJ, "Cyclophosphamide‐Induced Hypertensive Encephalopathy in a Young Girl With Lupus", The Journal of Clinical Hypertension, 2012 Apr .
How the study uses the data?
The study uses data from the FDA. It is based on cyclophosphamide (the active ingredients of Cyclophosphamide) and Cyclophosphamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Angiomyolipoma and Renal Mass - a second ago
- Acute Myeloid Leukaemia Aggravated and Dilatation Ventricular - 8 seconds ago
- Drug interactions of Allegra Allergy and Xiidra - 14 seconds ago
- Could Ceftriaxone cause Hallucinations? - 16 seconds ago
- Could Pantoprazole Sodium cause Ear Discomfort? - 17 seconds ago
- Acute Myeloid Leukaemia and Platelet Count Increased - 17 seconds ago
- Could Enhertu cause Haemoglobin Decreased? - 23 seconds ago
- Could Skyrizi cause The Flu? - 29 seconds ago
- Bipolar Disorder and Dyskinesia - 30 seconds ago
- Abdominal Pain Upper and Dyspnea - 45 seconds ago